PVI
PBYI icon

Pura Vida Investments’s Puma Biotechnology PBYI Stock Holding History

Pura Vida Investments’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-18,500
Closed -$718K – 118
2019
Q1 		$718K Buy
+18,500
New +$565K 0.1% 93
2017
Q4 		– Sell
-50,000
Closed -$3.55M – 91
2017
Q3 		$3.55M Buy
+50,000
New +$4.65M 0.63% 48

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fred Alger Management
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Pura Vida Investments's PBYI Position: Q2 2020 in Review

Pura Vida Investments sold out of Puma Biotechnology (PBYI) in Q2 2020, closing a stake of 64,000 shares — an estimated $540K sold.

Pura Vida Investments first reported a position in PBYI in Q3 2016 and held it in 3 quarters. The position peaked at $3.29M in Q3 2016. 128 funds tracked by Wall St. Rank hold PBYI as of Q2 2020.

  • Pura Vida Investments reported no remaining Puma Biotechnology position as of Q2 2020 after selling out during the quarter.
  • Pura Vida Investments sold 64,000 Puma Biotechnology shares in Q2 2020, an estimated $540K.
  • Pura Vida Investments first reported a position in Puma Biotechnology in Q3 2016 and held it in 3 quarters.
  • Pura Vida Investments's Puma Biotechnology position peaked at $3.29M in Q3 2016.
  • 128 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2020.

Based on Pura Vida Investments's 13F filing for Q2 2020, filed 14 Aug 2020.